the melphalan/misonidazole group had a superior response rate ( two complete and four partial responses among 42 patients or 14 % ) compared to the melphalan group in which there were no responses among 43 patients ( p = 0.024 , two-sided fisher exact test ) .
C0280679
melphalan/misonidazole
C0025241
melphalan